Gedatolisib is under clinical development by Celcuity and currently in Phase I for Cervical Cancer. According to GlobalData, Phase I drugs for Cervical Cancer have an 80% phase transition success rate ...
PAX-1 is under clinical development by Komipharm International and currently in Phase I for Cervical Cancer. According to GlobalData, Phase I drugs for Cervical Cancer have an 80% phase transition ...
as a monotherapy for the treatment of adult patients with second-line recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy. The approval means ...
Drug Improves Effectiveness of Radiation for Lung Cancer That Has Spread to the Brain Oct. 4, 2024 — The University of Cincinnati's Debanjan Bhattacharya is first author of new research ...
Dec. 23, 2024 — A research team has developed a groundbreaking technology that can treat colon cancer by converting cancer cells into a state resembling normal colon cells without killing them ...
the most commonly used system for classifying the spread of lung cancer in individual patients,” says Mitsudomi. The magnitude of the challenge faced in tackling lung cancer can seem overwhelmin ...
Patients with lung cancer, breast cancer, prostate cancer, cancer with an unknown primary site, or renal cancer are at high risk for the development of SCC by metastatic tumor. Spinal cord ...
Through Dec. 20, the FDA approved 50 brand new medicines, defined as proteins, small molecules, or other chemicals this year. That’s 9% fewer than in 2023, but still an impressive tally. In the 2000s, ...
negative nodes II Tumor of any size with adjacent spread (1/3 lower urethra, 1/3 lower vagina, anus), negative nodes IIIA Tumor of any size with positive inguino ...
The market value of Zai Lab has not appreciated considerably since my "Hold" sentiment. Check out why I'm transitioning from ...
Estimated numbers of new cancer cases and deaths in 2020 (In 2020, there will be an estimated 1.8 million new cancer cases diagnosed and 606,520 cancer deaths in the United States.) Current cancer ...